AFT lifts operating profit, forecasts growth of up to 58% this year

Jenny Ruth
Wed, 20 May 2020

AFT Pharmaceuticals reported annual operating profit near the top end of guidance and is forecasting underlying growth of up to 58 percent in the current year. The company, which owns the Maxigesic brand of tablets combining paracetamol and ibuprofen and related products, reported a bottom-line profit of $12.7 million for the 12 months ended March compared with a net loss of $2.4 million the previous year. Operating profit, which includes a one-off $9.8 million gain, rose to $21.2 million compared with guidance of $18.8 million to $21.8 m...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

My Net Worth FREE
My Net Worth: Zac Stephenson, managing director, MediaCom
Daniel Dunkley | Sun, 03 Jul 2022

MediaCom managing director Zac Stephenson says he's proud of surviving in the media industry, which can be stressful and intense. 

Finance FREE
Money Answers: what's the best share investing strategy in a recession?
Frances Cook | Sat, 02 Jul 2022

Spreading your money through good quality companies, then leaving it alone for a few years is the boring but most likely way to build wealth for most of us. 

On the Money
On The Money: Air NZ's feeding frenzy, Kerry Prendergast's movie date, and more
Pattrick Smellie | Sat, 02 Jul 2022

In this week's OTM: Greg Foran's preference for pies, Kerry Prendergast's future at the film commission, a blast from the past from Enable Networks, and more...

Digital innovation could shape the future of NZ

The digital age allows us to collaborate on some of our greatest scientific and environmental challenges

Investments to sustain the momentum of building in NZ

Classic Capital has opened its Land & Build fund to qualified wholesale and eligible investors.